Report

reporttype1Version of Safety Report ID2receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10060941serious1Date Last Updated08/05/2014receiptdateformat102companynumbUS-ABBVIE-14P-163-1218032-00occurcountryUSduplicate1Date Received04/04/2014seriousnesshospitalization1transmissiondate12/12/2014primarysourcecountryUS

Primary Source

reportercountryUSqualification5

Patient

Weight90.8SexMale

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
- 5)
- 6)
- 7)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionMuscle spasmsOutcomeRecovered/resolved

2)

reactionmeddraversionpt17.0ReactionMuscle spasmsOutcomeNot recovered/not resolved

3)

reactionmeddraversionpt17.0ReactionDrug ineffectiveOutcomeNot recovered/not resolved

4)

reactionmeddraversionpt17.0ReactionAbasiaOutcomeNot recovered/not resolved

5)

reactionmeddraversionpt17.0ReactionIncorrect dose administeredOutcomeNot recovered/not resolved

6)

reactionmeddraversionpt17.0ReactionConstipationOutcomeRecovered/resolved

7)

reactionmeddraversionpt17.0ReactionProduct quality issueOutcomeUnknown

Drug

1)

drugcharacterization1medicinalproductVICODIN 5/500drugbatchnumbUNKNOWNdrugauthorizationnumb088058drugstructuredosagenumb1drugstructuredosageunit032drugdosagetext1 IN 8 HOURdrugdosageformTABLETdrugadministrationroute048drugindicationMUSCLE SPASMSdrugenddateformat610drugenddate/03/2014actiondrug4

2)

drugcharacterization1medicinalproductVICODIN 5/500drugbatchnumbUNKNOWNdrugauthorizationnumb088058drugstructuredosagenumb1drugstructuredosageunit032drugseparatedosagenumb1drugintervaldosageunitnumb8drugintervaldosagedefinition805drugdosageformTABLETdrugadministrationroute048drugindicationGROIN PAINdrugstartdateformat610drugstartdate/03/2014actiondrug4

3)

drugcharacterization1medicinalproductVICODIN 5/500drugbatchnumbUNKNOWNdrugauthorizationnumb088058drugindicationPAINactiondrug4

4)

drugcharacterization1medicinalproductVICODIN ES 7.5/300 (MIKART)drugbatchnumbH120443Adrugstructuredosagenumb1drugstructuredosageunit032drugdosagetext30 PILLS GIVEN OF THE 7.5/300, TOOK 3, 4, 5 TABLETS AT TIME; 1 IN 8 HOURSdrugdosageformTABLETdrugadministrationroute048drugindicationMUSCLE SPASMSdrugstartdateformat102drugstartdate17/03/2014actiondrug4

5)

drugcharacterization1medicinalproductVICODIN ES 7.5/300 (MIKART)drugbatchnumbH120443AdrugindicationGROIN PAINactiondrug4

6)

drugcharacterization1medicinalproductVICODIN ES 7.5/300 (MIKART)drugbatchnumbH120443AdrugindicationPAINactiondrug4

7)

drugcharacterization2medicinalproductALTACEdrugindicationHYPERTENSION

openFDA Info on Medication

Application NumberNDA019901Brand NameALTACEGeneric NameRAMIPRILManufacturersPfizer Laboratories Div Pfizer Incproduct_ndc61570-110, 61570-111, 61570-112, 61570-120Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsRAMIPRILRXCUI104384, 104385, 198188, 198189, 260333, 261962, 845488, 845489spl_idadc257d2-f5aa-4353-b61b-5827e44040c9spl_set_id0fc34cd8-86e6-4034-73bd-4263a68ba046Package NDC61570-110-01, 61570-111-01, 61570-112-01, 61570-120-01NUIN0000175562, N0000000181Established Pharmacologic ClassAngiotensin Converting Enzyme Inhibitor [EPC]Mechanism of ActionAngiotensin-converting Enzyme Inhibitors [MoA]UNIIL35JN3I7SJ

8)

drugcharacterization2medicinalproductNEXIUMdrugindicationGASTROOESOPHAGEAL REFLUX DISEASE

openFDA Info on Medication

Application NumberNDA022101, NDA021957, NDA021153, NDA021689Brand NameNEXIUM, NEXIUM I.V.Generic NameESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE SODIUMManufacturersAstraZeneca Pharmaceuticals LPproduct_ndc 0186-4010, 0186-5020, 0186-4020, 0186-4040, 0186-5040, 0186-4025, 0186-4050, 018 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORAL, INTRAVENOUSActive IngredientsESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE SODIUMRXCUI 606726, 606728, 606730, 606731, 692576, 692578, 861568, 861570, 861576, 861583, ... spl_id416c365d-7271-4804-9285-643858cf578b, ac4ba22b-f431-4ab4-b239-0e220ad804ddspl_set_idf4853677-1622-4037-688b-fdf533a11d96, c325bbfc-46f3-471e-7bbc-ed0d6965d13bPackage NDC 0186-5020-31, 0186-5020-54, 0186-5020-82, 0186-4010-01, 0186-4010-02, 0186-4020- ... UNIIR6DXU4WAY9, L2C9GWQ43H

9)

drugcharacterization2medicinalproductLIPITORdrugindicationBLOOD CHOLESTEROL INCREASED

openFDA Info on Medication

Application NumberNDA020702Brand NameLIPITORGeneric NameATORVASTATIN CALCIUMManufacturersParke-Davis Div of Pfizer Incproduct_ndc0071-0155, 0071-0156, 0071-0157, 0071-0158Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsATORVASTATIN CALCIUM TRIHYDRATERXCUI259255, 262095, 617310, 617311, 617312, 617314, 617318, 617320spl_id0ba214c6-250e-42a0-aea8-5e44aba04882spl_set_idc6e131fe-e7df-4876-83f7-9156fc4e8228Package NDC 0071-0155-23, 0071-0155-40, 0071-0155-10, 0071-0155-97, 0071-0156-23, 0071-0156- ... UNII48A5M73Z4Q

10)

drugcharacterization2medicinalproductTUDORZA PRESSAIRdrugindicationCHRONIC OBSTRUCTIVE PULMONARY DISEASE

openFDA Info on Medication

Application NumberNDA202450Brand NameTUDORZA PRESSAIRGeneric NameACLIDINIUM BROMIDEManufacturersAstraZeneca Pharmaceuticals LP, Circassia Pharmaceuticals Inc.product_ndc0310-0800, 72124-002Product TypeHUMAN PRESCRIPTION DRUGRouteRESPIRATORY (INHALATION)Active IngredientsACLIDINIUM BROMIDERXCUI1303102, 1303107, 1607111, 1607112spl_idb74bd178-687b-4b46-a277-43c106c222fe, f976ce1a-f056-405a-af0a-958f4f6a1a46spl_set_idacdd5932-375b-4966-8a06-3806ab74c36d, 4cefdf4c-9e01-4b98-804b-c520f1b9716ePackage NDC 0310-0800-60, 0310-0800-95, 0310-0800-39, 72124-002-01, 72124-002-02, 72124-002- ... UNIIUQW7UF9N91

11)

drugcharacterization2medicinalproductTRAZODONEdrugindicationSLEEP DISORDER

12)

drugcharacterization2medicinalproductZOLOFTdrugindicationDEPRESSION

openFDA Info on Medication

Application NumberNDA020990, NDA019839Brand NameZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturersRoerigproduct_ndc0049-0050, 0049-4960, 0049-4900, 0049-4910Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI208149, 208161, 212233, 312938, 312940, 312941, 861064, 861066spl_id665a145d-44fb-4fef-a3c1-2aac26e0715cspl_set_idfe9e8b7d-61ea-409d-84aa-3ebd79a046b5Package NDC 0049-4960-30, 0049-4960-50, 0049-4900-30, 0049-4900-66, 0049-4900-73, 0049-4900- ... UNIIUTI8907Y6X

Report Duplicate

duplicatesourceABBVIEduplicatenumbUS-ABBVIE-14P-163-1218032-00

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

Drug

1)

2)

3)

4)

5)

6)

7)

openFDA Info on Medication

8)

openFDA Info on Medication

9)

openFDA Info on Medication

10)

openFDA Info on Medication

11)

12)

openFDA Info on Medication

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us